Showing results (111-120 of 149) with videos related to
Sort By:
Pageof 15
Human Immunology|December 1, 1990
Reassessment of HLA association with celiac disease in special reference to the DP associationM Colonna, W Mantovani, G R Corazza, et al.Molecular Immunology|October 1, 1995
The human antibody repertoire: heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigensJ S Andris, S R Abraham, V Pascual, et al.Tissue Antigens|February 12, 1998
HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencingC Pera, L Delfino, A Morabito, et al.European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 9, 2004
Alport syndrome: HLA association and kidney graft outcomeS Barocci, S Fiordoro, G Santori, et al.Immunogenetics|January 1, 1987
Human lymphoblastoid cell lines secreting antibodies with restricted HLA specificityM P Pistillo, N Tanigaki, O Mazzoleni, et al.Scandinavian Journal of Immunology|January 1, 1977
New groups and segregant series among B-cell alloantigens of the Merrit system. A study of leukemia cells, peripheral B cells, and lymphoblastoid cell linesR L Walford, G B Ferrara, R A Gatti, et al.European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|October 1, 1991
Analysis of HLA specificity of human monoclonal antibodies by cytofluorimetry and cell ELISAM P Pistillo, P L Tazzari, O Mazzoleni, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1976
The merrit alloantigenic system of human B lymphocytes: evidence for thirteen possible factors including one six-member segregant seriesR L Walford, T Gossett, G M Troup, et al.Clinical and Experimental Immunology|September 5, 2001
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clonesM Tommasi, D Castelletti, M Pasti, et al.The Journal of Pediatrics|January 1, 1994
Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapyT B Ferrara, R E Hoekstra, R J Couser, et al.Pageof 15